Krsnaa Diagnostics Q2 and H1 FY26 results: revenue and profit up
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.5 pts more than Nifty Microcap 250 and 9.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krsnaa Diagnostics reported consolidated revenue of Rs 3,989.7 million for H1 FY26, up about 12% YoY, with Q2 revenue at Rs 2,059.9 million. Consolidated PAT rose to Rs 444.7 million for H1 (up about 18.5%) and Rs 239.5 million for Q2 (up about 22%). Standalone PAT was Rs 428 million for H1. Auditors flagged an income tax demand of Rs 513.86 million from past search proceedings; the company has appealed and paid Rs 102.77 million under protest, with management saying it will not have a material impact.
Steady revenue and profit growth. Ongoing tax demand is a watch item; company and auditors expect no material impact on financials.